Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
Reads0
Chats0
TLDR
The relationship between systemic concentrations of NEFA and obesity/insulin resistance is examined and the vehicle by which triacylglycerol stored in adipose tissue is transported to its sites of utilization is recognized.Abstract:
There is a widespread acceptance in the literature that plasma nonesterified fatty acids (NEFA), also called free fatty acids (FFA), can mediate many adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obesity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mobilization from adipose tissue, normally suppressed by insulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains,” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story.
We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release.
NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health. Gordon demonstrated the origin of plasma NEFA from adipose tissue and their use by tissues such as the liver and myocardium, but not the brain.
We now recognize that NEFA are the vehicle by which triacylglycerol (TG) stored in adipose tissue is transported to its sites of utilization. NEFA turnover is rapid, with a plasma half-life around 2–4 min (6). The only significant site of NEFA liberation …read more
Citations
More filters
Journal ArticleDOI
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Un Ju Jung,Myung-Sook Choi +1 more
TL;DR: This review focuses on the role of several adipokines associated with obesity and the potential impact on obesity-related metabolic diseases.
Journal ArticleDOI
Mechanisms of Insulin Action and Insulin Resistance
TL;DR: This work aims to develop an integrated physiological perspective, placing the intricate signaling effectors that carry out the cell-autonomous response to insulin in the context of the tissue-specific functions that generate the coordinated organismal response.
Journal ArticleDOI
Dyslipidemia in Obesity: Mechanisms and Potential Targets
TL;DR: An important link between obesity, the metabolic syndrome and dyslipidemia, seems to be the development of insulin resistance in peripheral tissues leading to an enhanced hepatic flux of fatty acids from dietary sources, intravascular lipolysis and from adipose tissue resistant to the antilipolytic effects of insulin.
Journal ArticleDOI
Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.
Chih-Jung Chang,Chuan-Sheng Lin,Chia-Chen Lu,Jan Martel,Yun-Fei Ko,David M. Ojcius,Shun-Fu Tseng,Tsung-Ru Wu,Yi-Yuan Margaret Chen,John D. Young,Hsin-Chih Lai +10 more
TL;DR: The results indicate that G. lucidum and its high molecular weight polysaccharides may be used as prebiotic agents to prevent gut dysbiosis and obesity-related metabolic disorders in obese individuals.
Journal ArticleDOI
Mechanism linking diabetes mellitus and obesity.
TL;DR: The facts that link obesity with insulin resistance and pancreatic β-cell dysfunction are demonstrated and new approaches in managing and preventing diabetes in obese individuals must be studied and investigated based on the facts.
References
More filters
Journal ArticleDOI
The metabolic syndrome
TL;DR: The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated, and a proinflammatory state probably contributes to the metabolic syndrome.
Journal ArticleDOI
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
Journal ArticleDOI
A relation between non-esterified fatty acids in plasma and the metabolism of glucose
Journal ArticleDOI
Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration.
Johannes A. Romijn,Edward F. Coyle,Labros S. Sidossis,Amalia Gastaldelli,Jeffrey F. Horowitz,E. Endert,Robert R. Wolfe +6 more
TL;DR: It is concluded that, whereas carbohydrate availability is regulated directly in relation to exercise intensity, the regulation of lipid metabolism seems to be more complex.
Journal ArticleDOI
Mechanisms of fatty acid-induced inhibition of glucose uptake.
TL;DR: It is concluded that fatty acids caused a dose-dependent inhibition of insulin-stimulated glucose uptake (by decreasing glycogen synthesis and CHO oxidation) and that FFA and/or glycerol increased insulin-suppressed hepatic glucose output and thus caused insulin resistance at the peripheral and the hepatic level.